Core Viewpoint - Nestlé has initiated a global recall of infant formula products due to potential quality issues with ARA (Arachidonic Acid) sourced from suppliers, affecting over 50 countries and raising public concern about the safety of infant formula ingredients [1] Group 1: Company Responses - Mengniu stated that its ARA raw material suppliers are unrelated to the European recall incident, and all products undergo strict quality control [3] - Feihe confirmed that its ARA raw materials are not affected by any issues related to Bacillus cereus toxins, and the company adheres to stringent quality standards [3] - Junlebao mentioned that its ARA suppliers are Roget and Runke Bio, and the company follows internal control standards that exceed national regulations [3] - Danone emphasized that all its infant formula products are produced under high standards and do not use ARA from the suppliers involved in the recall [4] - Arla conducted a comprehensive review of its infant nutrition products and confirmed that its ARA suppliers are not linked to the recall issues [4] - HiPP stated that the ARA used in its products is sourced from suppliers not involved in the recall, ensuring safety and reliability [4] Group 2: Regulatory Oversight - The State Council's Food Safety Office and the Market Supervision Administration have urged Nestlé (China) to effectively manage the recall of affected products in China, ensuring consumer rights are protected [2] - The recall in the Chinese market includes four brands: Litojing, Platinum Enfamil, Shuyi Enfamil, and Wyeth's children's growth milk powder, totaling 30 batches [2]
飞鹤、蒙牛、君乐宝、达能、Arla、喜宝等多家乳企回应:所有产品中ARA目前无任何问题